James Hardie Ind Aktie

The ADR of James Hardie rose to a 52-week high of $31.38 and is trading just below at $31.32 after the share has gained 56.17% over the year (46% year-to-date). InvestingPro rates the company overall as "GOOD" but considers the stock overvalued relative to its fair value. James Hardie has agreed to sell its European Fermacell business to Holcim for around €840 million; Fitch confirmed the BBB rating and raised the outlook to "stable". Several brokers recently raised their assessments and price targets, including Barclays (Overweight) and Oppenheimer (price target $36.00). » More on de.investing.com

Fitch affirms James Hardie’s long-term issuer default rating at BBB and raises the outlook from negative to stable following the agreed sale of its European business Fermacell to Holcim for around €840m. The transaction implies an EBITDA multiple of 11.5 for FY2026 and is expected to close in H1 2027. Fitch expects net proceeds plus free cash flow to be used for debt repayment, which could reduce adjusted leverage to about 2.5x by end-FY2027; adjusted leverage was 3.9x at end-FY2026 (recently reduced to 3.2x). Fitch sees a path to higher EBITDA margins from assumed cost synergies, but views the loss of geographic diversification as negative. » More on de.investing.com

James Hardie Industries reported revenue of $1.47 billion for the first quarter, driven by organic growth of 20% in its core Siding & Trim business and higher volumes. Adjusted EBITDA amounted to $422 million, with a margin of 28.6%. Management subsequently raised its guidance. » More on finanzen.net